Regulation of Endothelial Constitutive Nitric Oxide Synthase Gene Expression in Endothelial Cells and In Vivo
Koji Kuboki(Joslin Diabetes Center), George L. King(Joslin Diabetes Center), Edward P. Feener(KalVista Pharmaceuticals (United States)), Christopher J. Rhodes(Centre for Human Genetics), Zhen Jiang(Fujian Medical University), Terrance P. Herbert(Joslin Diabetes Center), Sung Woo Ha(Joslin Diabetes Center), Masahiko Igarashi(Chiba University Hospital), Teruaki Yamauchi(Joslin Diabetes Center), Noriko Takahara(Joslin Diabetes Center)
Cited by 631
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
|Circulation Research|2010|979